Stoke Therapeutics Inc (STOK)
12.02
+0.33
(+2.82%)
USD |
NASDAQ |
May 03, 16:00
12.00
-0.02
(-0.17%)
After-Hours: 20:00
Stoke Therapeutics Net Income (TTM): -104.70M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -104.70M |
| September 30, 2023 | -103.40M |
| June 30, 2023 | -104.96M |
| March 31, 2023 | -98.96M |
| December 31, 2022 | -101.07M |
| September 30, 2022 | -99.86M |
| June 30, 2022 | -96.35M |
| March 31, 2022 | -93.66M |
| December 31, 2021 | -85.80M |
| September 30, 2021 | -75.92M |
| June 30, 2021 | -67.00M |
| Date | Value |
|---|---|
| March 31, 2021 | -58.00M |
| December 31, 2020 | -52.24M |
| September 30, 2020 | -47.84M |
| June 30, 2020 | -42.76M |
| March 31, 2020 | -37.62M |
| December 31, 2019 | -32.32M |
| September 30, 2019 | -26.45M |
| June 30, 2019 | -21.16M |
| March 31, 2019 | -16.35M |
| December 31, 2018 | -12.52M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-104.96M
Minimum
Jun 2023
-21.16M
Maximum
Jun 2019
-71.06M
Average
-75.92M
Median
Sep 2021
Net Income (TTM) Benchmarks
| NeuBase Therapeutics Inc | -13.73M |
| iBio Inc | -27.28M |
| Actinium Pharmaceuticals Inc | -46.45M |
| Lixte Biotechnology Holdings Inc | -5.087M |
| Fate Therapeutics Inc | -160.93M |